Sen. John M. Sullivan
Filed: 5/8/2007
|
|||||||
| |||||||
| |||||||
1 | AMENDMENT TO HOUSE BILL 118
| ||||||
2 | AMENDMENT NO. ______. Amend House Bill 118 by replacing | ||||||
3 | everything after the enacting clause with the following:
| ||||||
4 | "Section 5. The Illinois Dental Practice Act is amended by | ||||||
5 | adding Section 11.5 as follows: | ||||||
6 | (225 ILCS 25/11.5 new) | ||||||
7 | Sec. 11.5. Underserved population dental license pilot | ||||||
8 | program. | ||||||
9 | (a) The Department shall create an underserved population | ||||||
10 | dental license pilot program under which it shall issue | ||||||
11 | underserved population dental licenses to persons who are | ||||||
12 | graduates of a dental education program in a country other than | ||||||
13 | the United States or its territories or Canada and who hold a | ||||||
14 | current, valid license or authorization to practice dentistry | ||||||
15 | in a country other than the United States or its territories or | ||||||
16 | Canada. |
| |||||||
| |||||||
1 | (b) Persons holding underserved population dental licenses | ||||||
2 | may practice only in federally-designated dental health | ||||||
3 | professional shortage areas located in this State and must meet | ||||||
4 | each of the following qualifications: | ||||||
5 | (1) He or she must be a United States citizen or a | ||||||
6 | lawfully-admitted alien. | ||||||
7 | (2) He or she must be at least 21 years of age and of | ||||||
8 | good moral character. | ||||||
9 | (3) He or she must pass an examination authorized or | ||||||
10 | given by the Department in the theory and practice of the | ||||||
11 | science of dentistry, provided that the Department (i) may | ||||||
12 | recognize a certificate granted by the National Board of | ||||||
13 | Dental Examiners in lieu of or subject to such examination, | ||||||
14 | as may be required and (ii) may recognize the successful | ||||||
15 | completion of the clinical examination conducted by | ||||||
16 | approved regional testing services in lieu of such | ||||||
17 | examinations, as may be required. For the purposes of this | ||||||
18 | item (3), "successful completion" means that the applicant | ||||||
19 | has achieved a minimum passing score on the regional | ||||||
20 | examinations, as determined by each approved regional | ||||||
21 | testing service. | ||||||
22 | (4) He or she must present satisfactory evidence of the | ||||||
23 | completion of dental education by graduation from a dental | ||||||
24 | college or school outside of the United States or Canada | ||||||
25 | and provide satisfactory evidence that he or she has | ||||||
26 | achieved the same level of scientific knowledge and |
| |||||||
| |||||||
1 | clinical competence as required of all graduates of the | ||||||
2 | college, school, or advanced dental education program. | ||||||
3 | (c) In determining an applicant's professional capacity | ||||||
4 | for licensure under the pilot program, an individual who (i) | ||||||
5 | has not been actively engaged in the practice of dentistry, | ||||||
6 | (ii) has not been a dental student, or (iii) has not been | ||||||
7 | engaged in a formal program of dental education during the 5 | ||||||
8 | years immediately preceding the filing of an application may be | ||||||
9 | required to complete such additional testing, training, or | ||||||
10 | remedial education as the Board may deem necessary to establish | ||||||
11 | the applicant's present capacity to practice dentistry with | ||||||
12 | reasonable judgment, skill, and safety.
| ||||||
13 | (d) All candidates for licensure under the pilot program | ||||||
14 | must be certified by the Department. The Department may | ||||||
15 | contract with outside consultants or a national professional | ||||||
16 | organization to survey and evaluate candidates. Such | ||||||
17 | consultant or organization shall report to the Department | ||||||
18 | regarding its findings. | ||||||
19 | (e) An applicant for licensure under the pilot program who | ||||||
20 | has graduated from a dental education program outside of the | ||||||
21 | United States or Canada or its territories and whose first | ||||||
22 | language is not English must submit certification of passage of | ||||||
23 | the Test of English as a Foreign Language (TOEFL), as defined | ||||||
24 | by rule. The Department may, upon recommendation of the | ||||||
25 | certifying body, waive the requirement that the applicant pass | ||||||
26 | the TOEFL examination if the applicant submits verification of |
| |||||||
| |||||||
1 | the successful completion of a dental education program | ||||||
2 | conducted in English. | ||||||
3 | (f) Underserved population dental licensees must agree to | ||||||
4 | provide all allowable services under the dental programs | ||||||
5 | administered by the Department of Healthcare and Family | ||||||
6 | Services, including the Medicaid Program and the Covering ALL | ||||||
7 | KIDS Health Insurance Program. These allowable services | ||||||
8 | include without limitation preventative treatments, | ||||||
9 | endodontics, and crown and bridge work. An underserved | ||||||
10 | population dental licensee may not refuse to treat a patient | ||||||
11 | eligible under dental programs administered by the Department | ||||||
12 | of Healthcare and Family Services. | ||||||
13 | (g) An underserved population dental license shall be | ||||||
14 | automatically revoked if the licensee ceases to practice in the | ||||||
15 | federally-designated dental health professional shortage area. | ||||||
16 | An applicant must commit to practice under an underserved | ||||||
17 | population dental license for a period of 5 years. No more than | ||||||
18 | 50 underserved population dental licenses may be active at one | ||||||
19 | time. | ||||||
20 | (h) An underserved population dental licensee must be | ||||||
21 | supervised by a supervising dentist. The supervising dentist | ||||||
22 | shall be the primary dentist who, within his or her expertise, | ||||||
23 | may delegate a variety of tasks and procedures and may delegate | ||||||
24 | prescriptive authority to the underserved dental population | ||||||
25 | licensee. These tasks and procedures must be delegated within | ||||||
26 | established guidelines and the supervising dentist shall |
| |||||||
| |||||||
1 | maintain the final responsibility for the care of all patients | ||||||
2 | and the performance of the underserved population dental | ||||||
3 | licensee. Underserved population dental licensees may be | ||||||
4 | supervised only by dentists, as defined in this Act, who are | ||||||
5 | engaged in clinical practice or in clinical practice in public | ||||||
6 | health or other community health facilities. Each supervising | ||||||
7 | dentist shall file a notice of supervision of an underserved | ||||||
8 | population dental licensee, as established by rule. | ||||||
9 | An underserved population dental licensee may be employed | ||||||
10 | by a practice group or other entity employing multiple dentists | ||||||
11 | at one or more locations. In that case, one of the dentists | ||||||
12 | practicing at a location shall be designated the supervising | ||||||
13 | dentist. The other dentists with that practice group or other | ||||||
14 | entity who practice in the same general type of practice or | ||||||
15 | specialty as the supervising dentist may supervise the | ||||||
16 | underserved population dental licensees with respect to their | ||||||
17 | patients without being deemed alternate supervising dentists | ||||||
18 | for the purposes of this Section. | ||||||
19 | Nothing in this Section shall be construed to limit the | ||||||
20 | delegation of tasks or duties by a dentist to an underserved | ||||||
21 | dental population licensee or other appropriately trained | ||||||
22 | personnel. | ||||||
23 | Nothing in this Section shall be construed to prohibit the | ||||||
24 | employment of underserved population dental licensees by a | ||||||
25 | health care facility where such licensees function under the | ||||||
26 | supervision of a supervising dentist.
Duties of each |
| |||||||
| |||||||
1 | underserved population dental licensee are limited to those | ||||||
2 | within the scope of practice of the supervising dentist who is | ||||||
3 | fully responsible for all underserved dental population | ||||||
4 | licensee activities. | ||||||
5 | (i) Beginning 5 years after the effective date of this | ||||||
6 | amendatory Act of the 95th General Assembly, no new licenses | ||||||
7 | may be issued under the pilot program.
| ||||||
8 | (j) The Department shall adopt all rules necessary for the | ||||||
9 | administration of this Section.
| ||||||
10 | Section 10. The Illinois Controlled Substances Act is | ||||||
11 | amended by changing Section 102 as follows: | ||||||
12 | (720 ILCS 570/102) (from Ch. 56 1/2, par. 1102) | ||||||
13 | Sec. 102. Definitions. As used in this Act, unless the | ||||||
14 | context
otherwise requires:
| ||||||
15 | (a) "Addict" means any person who habitually uses any drug, | ||||||
16 | chemical,
substance or dangerous drug other than alcohol so as | ||||||
17 | to endanger the public
morals, health, safety or welfare or who | ||||||
18 | is so far addicted to the use of a
dangerous drug or controlled | ||||||
19 | substance other than alcohol as to have lost
the power of self | ||||||
20 | control with reference to his addiction.
| ||||||
21 | (b) "Administer" means the direct application of a | ||||||
22 | controlled
substance, whether by injection, inhalation, | ||||||
23 | ingestion, or any other
means, to the body of a patient, | ||||||
24 | research subject, or animal (as
defined by the Humane |
| |||||||
| |||||||
1 | Euthanasia in Animal Shelters Act) by:
| ||||||
2 | (1) a practitioner (or, in his presence, by his | ||||||
3 | authorized agent),
| ||||||
4 | (2) the patient or research subject at the lawful | ||||||
5 | direction of the
practitioner, or
| ||||||
6 | (3) a euthanasia technician as defined by the Humane | ||||||
7 | Euthanasia in
Animal Shelters Act.
| ||||||
8 | (c) "Agent" means an authorized person who acts on behalf | ||||||
9 | of or at
the direction of a manufacturer, distributor, or | ||||||
10 | dispenser. It does not
include a common or contract carrier, | ||||||
11 | public warehouseman or employee of
the carrier or warehouseman.
| ||||||
12 | (c-1) "Anabolic Steroids" means any drug or hormonal | ||||||
13 | substance,
chemically and pharmacologically related to | ||||||
14 | testosterone (other than
estrogens, progestins, and | ||||||
15 | corticosteroids) that promotes muscle growth,
and includes:
| ||||||
16 | (i) boldenone,
| ||||||
17 | (ii) chlorotestosterone,
| ||||||
18 | (iii) chostebol,
| ||||||
19 | (iv) dehydrochlormethyltestosterone,
| ||||||
20 | (v) dihydrotestosterone,
| ||||||
21 | (vi) drostanolone,
| ||||||
22 | (vii) ethylestrenol,
| ||||||
23 | (viii) fluoxymesterone,
| ||||||
24 | (ix) formebulone,
| ||||||
25 | (x) mesterolone,
| ||||||
26 | (xi) methandienone,
|
| |||||||
| |||||||
1 | (xii) methandranone,
| ||||||
2 | (xiii) methandriol,
| ||||||
3 | (xiv) methandrostenolone,
| ||||||
4 | (xv) methenolone,
| ||||||
5 | (xvi) methyltestosterone,
| ||||||
6 | (xvii) mibolerone,
| ||||||
7 | (xviii) nandrolone,
| ||||||
8 | (xix) norethandrolone,
| ||||||
9 | (xx) oxandrolone,
| ||||||
10 | (xxi) oxymesterone,
| ||||||
11 | (xxii) oxymetholone,
| ||||||
12 | (xxiii) stanolone,
| ||||||
13 | (xxiv) stanozolol,
| ||||||
14 | (xxv) testolactone,
| ||||||
15 | (xxvi) testosterone,
| ||||||
16 | (xxvii) trenbolone, and
| ||||||
17 | (xxviii) any salt, ester, or isomer of a drug or | ||||||
18 | substance described
or listed in this paragraph, if | ||||||
19 | that salt, ester, or isomer promotes muscle
growth.
| ||||||
20 | Any person who is otherwise lawfully in possession of an | ||||||
21 | anabolic
steroid, or who otherwise lawfully manufactures, | ||||||
22 | distributes, dispenses,
delivers, or possesses with intent to | ||||||
23 | deliver an anabolic steroid, which
anabolic steroid is | ||||||
24 | expressly intended for and lawfully allowed to be
administered | ||||||
25 | through implants to livestock or other nonhuman species, and
| ||||||
26 | which is approved by the Secretary of Health and Human Services |
| |||||||
| |||||||
1 | for such
administration, and which the person intends to | ||||||
2 | administer or have
administered through such implants, shall | ||||||
3 | not be considered to be in
unauthorized possession or to | ||||||
4 | unlawfully manufacture, distribute, dispense,
deliver, or | ||||||
5 | possess with intent to deliver such anabolic steroid for
| ||||||
6 | purposes of this Act.
| ||||||
7 | (d) "Administration" means the Drug Enforcement | ||||||
8 | Administration,
United States Department of Justice, or its | ||||||
9 | successor agency.
| ||||||
10 | (e) "Control" means to add a drug or other substance, or | ||||||
11 | immediate
precursor, to a Schedule under Article II of this Act | ||||||
12 | whether by
transfer from another Schedule or otherwise.
| ||||||
13 | (f) "Controlled Substance" means a drug, substance, or | ||||||
14 | immediate
precursor in the Schedules of Article II of this Act.
| ||||||
15 | (g) "Counterfeit substance" means a controlled substance, | ||||||
16 | which, or
the container or labeling of which, without | ||||||
17 | authorization bears the
trademark, trade name, or other | ||||||
18 | identifying mark, imprint, number or
device, or any likeness | ||||||
19 | thereof, of a manufacturer, distributor, or
dispenser other | ||||||
20 | than the person who in fact manufactured, distributed,
or | ||||||
21 | dispensed the substance.
| ||||||
22 | (h) "Deliver" or "delivery" means the actual, constructive | ||||||
23 | or
attempted transfer of possession of a controlled substance, | ||||||
24 | with or
without consideration, whether or not there is an | ||||||
25 | agency relationship.
| ||||||
26 | (i) "Department" means the Illinois Department of Human |
| |||||||
| |||||||
1 | Services (as
successor to the Department of Alcoholism and | ||||||
2 | Substance Abuse) or its successor agency.
| ||||||
3 | (j) "Department of State Police" means the Department of | ||||||
4 | State
Police of the State of Illinois or its successor agency.
| ||||||
5 | (k) "Department of Corrections" means the Department of | ||||||
6 | Corrections
of the State of Illinois or its successor agency.
| ||||||
7 | (l) "Department of Professional Regulation" means the | ||||||
8 | Department
of Professional Regulation of the State of Illinois | ||||||
9 | or its successor agency.
| ||||||
10 | (m) "Depressant" or "stimulant substance" means:
| ||||||
11 | (1) a drug which contains any quantity of (i) | ||||||
12 | barbituric acid or
any of the salts of barbituric acid | ||||||
13 | which has been designated as habit
forming under section | ||||||
14 | 502 (d) of the Federal Food, Drug, and Cosmetic
Act (21 | ||||||
15 | U.S.C. 352 (d)); or
| ||||||
16 | (2) a drug which contains any quantity of (i) | ||||||
17 | amphetamine or
methamphetamine and any of their optical | ||||||
18 | isomers; (ii) any salt of
amphetamine or methamphetamine or | ||||||
19 | any salt of an optical isomer of
amphetamine; or (iii) any | ||||||
20 | substance which the Department, after
investigation, has | ||||||
21 | found to be, and by rule designated as, habit forming
| ||||||
22 | because of its depressant or stimulant effect on the | ||||||
23 | central nervous
system; or
| ||||||
24 | (3) lysergic acid diethylamide; or
| ||||||
25 | (4) any drug which contains any quantity of a substance | ||||||
26 | which the
Department, after investigation, has found to |
| |||||||
| |||||||
1 | have, and by rule
designated as having, a potential for | ||||||
2 | abuse because of its depressant or
stimulant effect on the | ||||||
3 | central nervous system or its hallucinogenic
effect.
| ||||||
4 | (n) (Blank).
| ||||||
5 | (o) "Director" means the Director of the Department of | ||||||
6 | State Police or
the Department of Professional Regulation or | ||||||
7 | his designated agents.
| ||||||
8 | (p) "Dispense" means to deliver a controlled substance to | ||||||
9 | an
ultimate user or research subject by or pursuant to the | ||||||
10 | lawful order of
a prescriber, including the prescribing, | ||||||
11 | administering, packaging,
labeling, or compounding necessary | ||||||
12 | to prepare the substance for that
delivery.
| ||||||
13 | (q) "Dispenser" means a practitioner who dispenses.
| ||||||
14 | (r) "Distribute" means to deliver, other than by | ||||||
15 | administering or
dispensing, a controlled substance.
| ||||||
16 | (s) "Distributor" means a person who distributes.
| ||||||
17 | (t) "Drug" means (1) substances recognized as drugs in the | ||||||
18 | official
United States Pharmacopoeia, Official Homeopathic | ||||||
19 | Pharmacopoeia of the
United States, or official National | ||||||
20 | Formulary, or any supplement to any
of them; (2) substances | ||||||
21 | intended for use in diagnosis, cure, mitigation,
treatment, or | ||||||
22 | prevention of disease in man or animals; (3) substances
(other | ||||||
23 | than food) intended to affect the structure of any function of
| ||||||
24 | the body of man or animals and (4) substances intended for use | ||||||
25 | as a
component of any article specified in clause (1), (2), or | ||||||
26 | (3) of this
subsection. It does not include devices or their |
| |||||||
| |||||||
1 | components, parts, or
accessories.
| ||||||
2 | (t-5) "Euthanasia agency" means
an entity certified by the | ||||||
3 | Department of Professional Regulation for the
purpose of animal | ||||||
4 | euthanasia that holds an animal control facility license or
| ||||||
5 | animal
shelter license under the Animal Welfare Act. A | ||||||
6 | euthanasia agency is
authorized to purchase, store, possess, | ||||||
7 | and utilize Schedule II nonnarcotic and
Schedule III | ||||||
8 | nonnarcotic drugs for the sole purpose of animal euthanasia.
| ||||||
9 | (t-10) "Euthanasia drugs" means Schedule II or Schedule III | ||||||
10 | substances
(nonnarcotic controlled substances) that are used | ||||||
11 | by a euthanasia agency for
the purpose of animal euthanasia.
| ||||||
12 | (u) "Good faith" means the prescribing or dispensing of a | ||||||
13 | controlled
substance by a practitioner in the regular course of | ||||||
14 | professional
treatment to or for any person who is under his | ||||||
15 | treatment for a
pathology or condition other than that | ||||||
16 | individual's physical or
psychological dependence upon or | ||||||
17 | addiction to a controlled substance,
except as provided herein: | ||||||
18 | and application of the term to a pharmacist
shall mean the | ||||||
19 | dispensing of a controlled substance pursuant to the
| ||||||
20 | prescriber's order which in the professional judgment of the | ||||||
21 | pharmacist
is lawful. The pharmacist shall be guided by | ||||||
22 | accepted professional
standards including, but not limited to | ||||||
23 | the following, in making the
judgment:
| ||||||
24 | (1) lack of consistency of doctor-patient | ||||||
25 | relationship,
| ||||||
26 | (2) frequency of prescriptions for same drug by one |
| |||||||
| |||||||
1 | prescriber for
large numbers of patients,
| ||||||
2 | (3) quantities beyond those normally prescribed,
| ||||||
3 | (4) unusual dosages,
| ||||||
4 | (5) unusual geographic distances between patient, | ||||||
5 | pharmacist and
prescriber,
| ||||||
6 | (6) consistent prescribing of habit-forming drugs.
| ||||||
7 | (u-1) "Home infusion services" means services provided by a | ||||||
8 | pharmacy in
compounding solutions for direct administration to | ||||||
9 | a patient in a private
residence, long-term care facility, or | ||||||
10 | hospice setting by means of parenteral,
intravenous, | ||||||
11 | intramuscular, subcutaneous, or intraspinal infusion.
| ||||||
12 | (v) "Immediate precursor" means a substance:
| ||||||
13 | (1) which the Department has found to be and by rule | ||||||
14 | designated as
being a principal compound used, or produced | ||||||
15 | primarily for use, in the
manufacture of a controlled | ||||||
16 | substance;
| ||||||
17 | (2) which is an immediate chemical intermediary used or | ||||||
18 | likely to
be used in the manufacture of such controlled | ||||||
19 | substance; and
| ||||||
20 | (3) the control of which is necessary to prevent, | ||||||
21 | curtail or limit
the manufacture of such controlled | ||||||
22 | substance.
| ||||||
23 | (w) "Instructional activities" means the acts of teaching, | ||||||
24 | educating
or instructing by practitioners using controlled | ||||||
25 | substances within
educational facilities approved by the State | ||||||
26 | Board of Education or
its successor agency.
|
| |||||||
| |||||||
1 | (x) "Local authorities" means a duly organized State, | ||||||
2 | County or
Municipal peace unit or police force.
| ||||||
3 | (y) "Look-alike substance" means a substance, other than a | ||||||
4 | controlled
substance which (1) by overall dosage unit | ||||||
5 | appearance, including shape,
color, size, markings or lack | ||||||
6 | thereof, taste, consistency, or any other
identifying physical | ||||||
7 | characteristic of the substance, would lead a reasonable
person | ||||||
8 | to believe that the substance is a controlled substance, or (2) | ||||||
9 | is
expressly or impliedly represented to be a controlled | ||||||
10 | substance or is
distributed under circumstances which would | ||||||
11 | lead a reasonable person to
believe that the substance is a | ||||||
12 | controlled substance. For the purpose of
determining whether | ||||||
13 | the representations made or the circumstances of the
| ||||||
14 | distribution would lead a reasonable person to believe the | ||||||
15 | substance to be
a controlled substance under this clause (2) of | ||||||
16 | subsection (y), the court or
other authority may consider the | ||||||
17 | following factors in addition to any other
factor that may be | ||||||
18 | relevant:
| ||||||
19 | (a) statements made by the owner or person in control | ||||||
20 | of the substance
concerning its nature, use or effect;
| ||||||
21 | (b) statements made to the buyer or recipient that the | ||||||
22 | substance may
be resold for profit;
| ||||||
23 | (c) whether the substance is packaged in a manner | ||||||
24 | normally used for the
illegal distribution of controlled | ||||||
25 | substances;
| ||||||
26 | (d) whether the distribution or attempted distribution |
| |||||||
| |||||||
1 | included an
exchange of or demand for money or other | ||||||
2 | property as consideration, and
whether the amount of the | ||||||
3 | consideration was substantially greater than the
| ||||||
4 | reasonable retail market value of the substance.
| ||||||
5 | Clause (1) of this subsection (y) shall not apply to a | ||||||
6 | noncontrolled
substance in its finished dosage form that was | ||||||
7 | initially introduced into
commerce prior to the initial | ||||||
8 | introduction into commerce of a controlled
substance in its | ||||||
9 | finished dosage form which it may substantially resemble.
| ||||||
10 | Nothing in this subsection (y) prohibits the dispensing or | ||||||
11 | distributing
of noncontrolled substances by persons authorized | ||||||
12 | to dispense and
distribute controlled substances under this | ||||||
13 | Act, provided that such action
would be deemed to be carried | ||||||
14 | out in good faith under subsection (u) if the
substances | ||||||
15 | involved were controlled substances.
| ||||||
16 | Nothing in this subsection (y) or in this Act prohibits the | ||||||
17 | manufacture,
preparation, propagation, compounding, | ||||||
18 | processing, packaging, advertising
or distribution of a drug or | ||||||
19 | drugs by any person registered pursuant to
Section 510 of the | ||||||
20 | Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360).
| ||||||
21 | (y-1) "Mail-order pharmacy" means a pharmacy that is | ||||||
22 | located in a state
of the United States, other than Illinois, | ||||||
23 | that delivers, dispenses or
distributes, through the United | ||||||
24 | States Postal Service or other common
carrier, to Illinois | ||||||
25 | residents, any substance which requires a prescription.
| ||||||
26 | (z) "Manufacture" means the production, preparation, |
| |||||||
| |||||||
1 | propagation,
compounding, conversion or processing of a | ||||||
2 | controlled substance other than methamphetamine, either
| ||||||
3 | directly or indirectly, by extraction from substances of | ||||||
4 | natural origin,
or independently by means of chemical | ||||||
5 | synthesis, or by a combination of
extraction and chemical | ||||||
6 | synthesis, and includes any packaging or
repackaging of the | ||||||
7 | substance or labeling of its container, except that
this term | ||||||
8 | does not include:
| ||||||
9 | (1) by an ultimate user, the preparation or compounding | ||||||
10 | of a
controlled substance for his own use; or
| ||||||
11 | (2) by a practitioner, or his authorized agent under | ||||||
12 | his
supervision, the preparation, compounding, packaging, | ||||||
13 | or labeling of a
controlled substance:
| ||||||
14 | (a) as an incident to his administering or | ||||||
15 | dispensing of a
controlled substance in the course of | ||||||
16 | his professional practice; or
| ||||||
17 | (b) as an incident to lawful research, teaching or | ||||||
18 | chemical
analysis and not for sale.
| ||||||
19 | (z-1) (Blank).
| ||||||
20 | (aa) "Narcotic drug" means any of the following, whether | ||||||
21 | produced
directly or indirectly by extraction from substances | ||||||
22 | of natural origin,
or independently by means of chemical | ||||||
23 | synthesis, or by a combination of
extraction and chemical | ||||||
24 | synthesis:
| ||||||
25 | (1) opium and opiate, and any salt, compound, | ||||||
26 | derivative, or
preparation of opium or opiate;
|
| |||||||
| |||||||
1 | (2) any salt, compound, isomer, derivative, or | ||||||
2 | preparation thereof
which is chemically equivalent or | ||||||
3 | identical with any of the substances
referred to in clause | ||||||
4 | (1), but not including the isoquinoline alkaloids
of opium;
| ||||||
5 | (3) opium poppy and poppy straw;
| ||||||
6 | (4) coca leaves and any salts, compound, isomer, salt | ||||||
7 | of an isomer,
derivative, or preparation of coca leaves | ||||||
8 | including cocaine or ecgonine,
and any salt, compound, | ||||||
9 | isomer, derivative, or preparation thereof which is
| ||||||
10 | chemically equivalent or identical with any of these | ||||||
11 | substances, but not
including decocainized coca leaves or | ||||||
12 | extractions of coca leaves which do
not contain cocaine or | ||||||
13 | ecgonine (for the purpose of this paragraph, the
term | ||||||
14 | "isomer" includes optical, positional and geometric | ||||||
15 | isomers).
| ||||||
16 | (bb) "Nurse" means a registered nurse licensed under the
| ||||||
17 | Nursing and Advanced Practice Nursing Act.
| ||||||
18 | (cc) (Blank).
| ||||||
19 | (dd) "Opiate" means any substance having an addiction | ||||||
20 | forming or
addiction sustaining liability similar to morphine | ||||||
21 | or being capable of
conversion into a drug having addiction | ||||||
22 | forming or addiction sustaining
liability.
| ||||||
23 | (ee) "Opium poppy" means the plant of the species Papaver
| ||||||
24 | somniferum L., except its seeds.
| ||||||
25 | (ff) "Parole and Pardon Board" means the Parole and Pardon | ||||||
26 | Board of
the State of Illinois or its successor agency.
|
| |||||||
| |||||||
1 | (gg) "Person" means any individual, corporation, | ||||||
2 | mail-order pharmacy,
government or governmental subdivision or | ||||||
3 | agency, business trust, estate,
trust, partnership or | ||||||
4 | association, or any other entity.
| ||||||
5 | (hh) "Pharmacist" means any person who holds a certificate | ||||||
6 | of
registration as a registered pharmacist, a local registered | ||||||
7 | pharmacist
or a registered assistant pharmacist under the | ||||||
8 | Pharmacy Practice Act of 1987.
| ||||||
9 | (ii) "Pharmacy" means any store, ship or other place in | ||||||
10 | which
pharmacy is authorized to be practiced under the Pharmacy | ||||||
11 | Practice Act of 1987.
| ||||||
12 | (jj) "Poppy straw" means all parts, except the seeds, of | ||||||
13 | the opium
poppy, after mowing.
| ||||||
14 | (kk) "Practitioner" means a physician licensed to practice | ||||||
15 | medicine in all
its branches, dentist, podiatrist,
| ||||||
16 | veterinarian, scientific investigator, pharmacist, physician | ||||||
17 | assistant,
advanced practice nurse,
licensed practical
nurse, | ||||||
18 | registered nurse, hospital, laboratory, or pharmacy, or other
| ||||||
19 | person licensed, registered, or otherwise lawfully permitted | ||||||
20 | by the
United States or this State to distribute, dispense, | ||||||
21 | conduct research
with respect to, administer or use in teaching | ||||||
22 | or chemical analysis, a
controlled substance in the course of | ||||||
23 | professional practice or research.
| ||||||
24 | (ll) "Pre-printed prescription" means a written | ||||||
25 | prescription upon which
the designated drug has been indicated | ||||||
26 | prior to the time of issuance.
|
| |||||||
| |||||||
1 | (mm) "Prescriber" means a physician licensed to practice | ||||||
2 | medicine in all
its branches, dentist, podiatrist or
| ||||||
3 | veterinarian who issues a prescription, a physician assistant | ||||||
4 | who
issues a
prescription for a Schedule III, IV, or V | ||||||
5 | controlled substance
in accordance
with Section 303.05 and the | ||||||
6 | written guidelines required under Section 7.5
of the
Physician | ||||||
7 | Assistant Practice Act of 1987, or an advanced practice
nurse | ||||||
8 | with prescriptive authority in accordance with Section 303.05
| ||||||
9 | and a written
collaborative agreement under Sections 15-15 and | ||||||
10 | 15-20 of
the Nursing and Advanced Practice Nursing Act , or an | ||||||
11 | underserved dental population licensee with prescriptive | ||||||
12 | authority in accordance with Section 11.5 of the Illinois | ||||||
13 | Dental Practice Act .
| ||||||
14 | (nn) "Prescription" means a lawful written, facsimile, or | ||||||
15 | verbal order
of
a physician licensed to practice medicine in | ||||||
16 | all its branches,
dentist, podiatrist or veterinarian for any | ||||||
17 | controlled
substance, of a physician assistant for a Schedule | ||||||
18 | III, IV, or V
controlled substance
in accordance with Section | ||||||
19 | 303.05 and the written guidelines required under
Section 7.5 of | ||||||
20 | the
Physician Assistant Practice Act of 1987, or of an advanced | ||||||
21 | practice
nurse who issues a prescription for a Schedule III, | ||||||
22 | IV, or V
controlled substance in accordance
with
Section 303.05 | ||||||
23 | and a written collaborative agreement under Sections 15-15
and
| ||||||
24 | 15-20 of the Nursing and Advanced Practice Nursing Act.
| ||||||
25 | (oo) "Production" or "produce" means manufacture, | ||||||
26 | planting,
cultivating, growing, or harvesting of a controlled |
| |||||||
| |||||||
1 | substance other than methamphetamine.
| ||||||
2 | (pp) "Registrant" means every person who is required to | ||||||
3 | register
under Section 302 of this Act.
| ||||||
4 | (qq) "Registry number" means the number assigned to each | ||||||
5 | person
authorized to handle controlled substances under the | ||||||
6 | laws of the United
States and of this State.
| ||||||
7 | (rr) "State" includes the State of Illinois and any state, | ||||||
8 | district,
commonwealth, territory, insular possession thereof, | ||||||
9 | and any area
subject to the legal authority of the United | ||||||
10 | States of America.
| ||||||
11 | (ss) "Ultimate user" means a person who lawfully possesses | ||||||
12 | a
controlled substance for his own use or for the use of a | ||||||
13 | member of his
household or for administering to an animal owned | ||||||
14 | by him or by a member
of his household.
| ||||||
15 | (Source: P.A. 93-596, eff. 8-26-03; 93-626, eff. 12-23-03; | ||||||
16 | 94-556, eff. 9-11-05.)
| ||||||
17 | Section 99. Effective date. This Act takes effect upon | ||||||
18 | becoming law.".
|